PortfoliosLab logoPortfoliosLab logo
NAGE vs. GTX
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

NAGE vs. GTX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Niagen Bioscience, Inc (NAGE) and Garrett Motion Inc. (GTX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, NAGE achieves a -45.91% return, which is significantly lower than GTX's 86.73% return.


NAGE

1D
-2.82%
1M
-30.22%
YTD
-45.91%
6M
-47.32%
1Y
-70.80%
3Y*
31.29%
5Y*
-17.39%
10Y*
-5.02%

GTX

1D
2.41%
1M
29.68%
YTD
86.73%
6M
94.66%
1Y
224.03%
3Y*
57.45%
5Y*
32.32%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

NAGE vs. GTX - Yearly Performance Comparison


2026 (YTD)20252024202320222021202020192018
NAGE
Niagen Bioscience, Inc
-45.91%19.89%270.98%-14.88%-55.08%-22.08%11.37%25.66%-8.78%
GTX
Garrett Motion Inc.
86.73%97.23%-6.62%26.90%-5.11%81.26%-55.66%-19.04%-35.66%

Correlation

The correlation between NAGE and GTX is 0.28, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.28

Correlation (3Y)
Calculated over the trailing 3-year period

0.16

Correlation (5Y)
Calculated over the trailing 5-year period

0.19

Correlation (All Time)
Calculated using the full available price history since Sep 18, 2018

0.14

The correlation between NAGE and GTX shifts across timeframes, from 0.14 (all time) to 0.28 (1 year), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

NAGE:

$290.91M

GTX:

$6.25B

EPS

NAGE:

$0.22

GTX:

$1.72

PE Ratio

NAGE:

15.78

GTX:

18.81

PEG Ratio

NAGE:

0.13

GTX:

0.15

PS Ratio

NAGE:

2.25

GTX:

2.38

Total Revenue (TTM)

NAGE:

$130.42M

GTX:

$2.71B

Gross Profit (TTM)

NAGE:

$83.83M

GTX:

$855.00M

EBITDA (TTM)

NAGE:

$13.37M

GTX:

$452.00M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

NAGE vs. GTX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NAGE
NAGE Risk / Return Rank: 33
Overall Rank
NAGE Sharpe Ratio Rank: 11
Sharpe Ratio Rank
NAGE Sortino Ratio Rank: 11
Sortino Ratio Rank
NAGE Omega Ratio Rank: 22
Omega Ratio Rank
NAGE Calmar Ratio Rank: 55
Calmar Ratio Rank
NAGE Martin Ratio Rank: 99
Martin Ratio Rank

GTX
GTX Risk / Return Rank: 9898
Overall Rank
GTX Sharpe Ratio Rank: 9898
Sharpe Ratio Rank
GTX Sortino Ratio Rank: 9999
Sortino Ratio Rank
GTX Omega Ratio Rank: 9898
Omega Ratio Rank
GTX Calmar Ratio Rank: 9898
Calmar Ratio Rank
GTX Martin Ratio Rank: 9898
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NAGE vs. GTX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Niagen Bioscience, Inc (NAGE) and Garrett Motion Inc. (GTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


NAGEGTXDifference
Sharpe ratioReturn per unit of total volatility

-6.09

Sortino ratioReturn per unit of downside risk

-9.21

Omega ratioGain probability vs. loss probability

0.70

1.81

-1.11

Calmar ratioReturn relative to maximum drawdown

-0.93

11.35

-12.28

Martin ratioReturn relative to average drawdown

-1.36

36.89

-38.25

NAGE vs. GTX - Sharpe Ratio Comparison

The current NAGE Sharpe Ratio is -1.36, which is lower than the GTX Sharpe Ratio of 4.73. The chart below compares the historical Sharpe Ratios of NAGE and GTX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


NAGEGTXDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-1.36

4.73

-6.09

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.23

0.78

-1.01

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

-0.06

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.03

0.12

-0.15

Drawdowns

NAGE vs. GTX - Drawdown Comparison

The maximum NAGE drawdown since its inception was -97.00%, roughly equal to the maximum GTX drawdown of -93.08%. Use the drawdown chart below to compare losses from any high point for NAGE and GTX.


Loading charts...

Drawdown Indicators


NAGEGTXDifference

Max Drawdown

Largest peak-to-trough decline

-97.00%

-93.08%

-3.92%

Max Drawdown (1Y)

Largest decline over 1 year

-76.13%

-19.87%

-56.26%

Max Drawdown (3Y)

Largest decline over 3 years

-76.13%

-26.82%

-49.31%

Max Drawdown (5Y)

Largest decline over 5 years

-88.71%

-32.07%

-56.64%

Max Drawdown (10Y)

Largest decline over 10 years

-93.65%

Current Drawdown

Current decline from peak

-81.64%

-4.37%

-77.27%

Average Drawdown

Average peak-to-trough decline

-75.72%

-51.03%

-24.69%

Ulcer Index

Depth and duration of drawdowns from previous peaks

52.25%

6.10%

+46.15%

Volatility

NAGE vs. GTX - Volatility Comparison

Niagen Bioscience, Inc (NAGE) has a higher volatility of 20.67% compared to Garrett Motion Inc. (GTX) at 14.73%. This indicates that NAGE's price experiences larger fluctuations and is considered to be riskier than GTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


NAGEGTXDifference

Volatility (1M)

Calculated over the trailing 1-month period

20.67%

14.73%

+5.94%

Volatility (6M)

Calculated over the trailing 6-month period

34.51%

34.81%

-0.30%

Volatility (1Y)

Calculated over the trailing 1-year period

52.25%

47.66%

+4.59%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

77.24%

41.55%

+35.69%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

80.01%

64.00%

+16.01%

Dividends

NAGE vs. GTX - Dividend Comparison

NAGE has not paid dividends to shareholders, while GTX's dividend yield for the trailing twelve months is around 0.93%.


PositionTTM2025
GTX
Garrett Motion Inc.
0.93%1.49%
NAGE
Niagen Bioscience, Inc
0.00%0.00%

Financials

NAGE vs. GTX - Financials Comparison

This section allows you to compare key financial metrics between Niagen Bioscience, Inc and Garrett Motion Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00200.00M400.00M600.00M800.00M1.00B20222023202420252026
31.47M
0
(NAGE) Total Revenue
(GTX) Total Revenue
Values in USD except per share items

Frequently Asked Questions


NAGE and GTX have a correlation of 0.28, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

NAGE has higher volatility (20.67%) compared to GTX (14.73%). In terms of maximum drawdown, NAGE dropped -97.00% vs GTX's -93.08%.

GTX currently has the higher Sharpe Ratio (4.73 vs -1.36), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for NAGE and GTX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer